Protagenic Therapeutics, Inc.
PTIX
$1.80
-$0.10-5.03%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -49.30% | -1,459.03% | |||
| Total Depreciation and Amortization | -- | -- | |||
| Total Amortization of Deferred Charges | -100.00% | -- | |||
| Total Other Non-Cash Items | -- | -- | |||
| Change in Net Operating Assets | -1,783.21% | 475.48% | |||
| Cash from Operations | -339.63% | -373.74% | |||
| Capital Expenditure | -- | -- | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | -- | |||
| Cash from Investing | 100.00% | -- | |||
| Total Debt Issued | -101.85% | -93.64% | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | 2,172,500.00% | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | 88.14% | 359.48% | |||
| Foreign Exchange rate Adjustments | 127.48% | -2,690.48% | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -113.91% | 473.27% | |||